The impact of empagliflozin on eGFR and albuminuria: results from the ABCD nationwide empagliflozin audit

TSJ Crabtree^1,2,3, J Elliott⁴, A Bickerton⁵, A Evans⁶, S Phillips⁶, K Dhatariya⁷, I Gallen⁸, REJ Ryder¹; on behalf of ABCD empagliflozin audit contributors⁹

1 Sandwell and West Birmingham Hospitals NHS Trust

2 University Hospitals of Derby and Burton NHS Trust

3 University of Nottingham

4. Sheffield Teaching Hospitals NHS Trust

5 Yeovil District Hospitals NHS Foundation Trust

6 Gloucestershire Hospitals NHS Trust

7 Norfolk and Norwich NHS Trust

8 Royal Berkshire NHS Foundation Trust

9 Association of British Clinical Diabetologists